Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (SHA:603811)

SHA:603811 Revenue

Zhejiang Cheng Yi Pharmaceutical had revenue of 201.00M CNY in the quarter ending March 31, 2026, with 8.30% growth. This brings the company's revenue in the last twelve months to 827.75M, up 10.82% year-over-year. In the year 2025, Zhejiang Cheng Yi Pharmaceutical had annual revenue of 812.35M with 13.72% growth.

• Revenue (ttm): 827.75M
• Revenue Growth: +10.82%
• P/S Ratio: 4.01
• Revenue / Employee: 1.37M
• Employees: 604
• Market Cap: 3.32B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	812.35M	97.98M	13.72%
Dec 31, 2024	714.37M	42.74M	6.36%
Dec 31, 2023	671.63M	16.65M	2.54%
Dec 31, 2022	654.97M	-38.99M	-5.62%
Dec 31, 2021	693.96M	-64.17M	-8.46%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 10, 2026

Data Sources Report a data error